ALVR RSI Chart
Last 7 days
-1.3%
Last 30 days
2.6%
Last 90 days
11.4%
Trailing 12 Months
-81.0%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
May 03, 2024 | sinha vikas | sold | -3,945 | 0.796 | -4,957 | see remarks |
May 03, 2024 | hagen brett r | sold | -1,271 | 0.796 | -1,597 | chief accounting officer |
May 03, 2024 | brainard diana | sold | -8,151 | 0.796 | -10,240 | chief executive officer |
May 03, 2024 | miller edward | sold | -1,839 | 0.796 | -2,311 | general counsel |
Apr 22, 2024 | sinha vikas | sold | -1,392 | 0.75 | -1,857 | see remarks |
Apr 22, 2024 | hagen brett r | sold | -360 | 0.75 | -480 | chief accounting officer |
Apr 22, 2024 | miller edward | sold | -567 | 0.75 | -757 | general counsel |
Apr 19, 2024 | miller edward | sold | -469 | 0.7506 | -626 | general counsel |
Apr 19, 2024 | hagen brett r | sold | -355 | 0.7506 | -473 | chief accounting officer |
Apr 19, 2024 | sinha vikas | sold | -1,141 | 0.7506 | -1,521 | see remarks |
Which funds bought or sold ALVR recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 17, 2024 | Artal Group S.A. | unchanged | - | 495,201 | 4,980,200 | 0.13% |
May 16, 2024 | JANE STREET GROUP, LLC | sold off | -100 | -43,322 | - | -% |
May 16, 2024 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | sold off | -100 | -5,696 | - | -% |
May 15, 2024 | Graham Capital Management, L.P. | sold off | -100 | -55,912 | - | -% |
May 15, 2024 | TWO SIGMA INVESTMENTS, LP | added | 20.14 | 60,098 | 239,942 | -% |
May 15, 2024 | MARSHALL WACE, LLP | added | 12.47 | 53,085 | 273,853 | -% |
May 15, 2024 | AMUNDI | unchanged | - | 2,822 | 33,727 | -% |
May 15, 2024 | TWO SIGMA ADVISERS, LP | added | 202 | 158,098 | 225,262 | -% |
May 15, 2024 | 683 Capital Management, LLC | sold off | -100 | -129,557 | - | -% |
May 15, 2024 | Redmile Group, LLC | unchanged | - | 143,289 | 1,440,330 | 0.05% |
Unveiling AlloVir, Inc.'s Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to AlloVir, Inc.)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 50.9B | 6.8B | -8.53 | 7.44 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 18.9B | 2.0B | -56.9 | 9.43 | ||||
BMRN | 14.7B | 2.5B | 71.65 | 5.96 | ||||
INCY | 12.8B | 3.8B | 17.2 | 3.4 | ||||
MID-CAP | ||||||||
BBIO | 5.6B | 107.9M | -10.31 | 48.09 | ||||
APLS | 5.0B | 524.1M | -12.02 | 9.57 | ||||
AXSM | 3.6B | 251.0M | -12.28 | 14.5 | ||||
ARWR | 3.1B | 240.7M | -6.53 | 12.77 | ||||
ACAD | 2.4B | 813.8M | -1.4K | 3 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 29.91 | 4.73 | ||||
NVAX | 1.8B | 996.6M | -4.58 | 1.83 | ||||
CRBP | 480.9M | 881.7K | -14.25 | 481.06 | ||||
INO | 310.9M | 4.9M | -2.49 | 63.89 | ||||
IBIO | 17.1M | 2.1M | -0.74 | 7.61 |
AlloVir, Inc. News
Balance Sheet | ||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2019Q4 |
Assets | -24.5% | 144 | 191 | 248 | 283 | 244 | 277 | 294 | 200 | 231 | 287 | 317 | 328 | 351 | 371 | 394 | 118 | 139 |
Current Assets | -24.6% | 141 | 188 | 220 | 253 | 212 | 243 | 272 | 177 | 206 | 253 | 282 | 316 | 340 | 361 | 384 | 107 | 127 |
Cash Equivalents | -4.5% | 86.00 | 90.00 | 96.00 | 197 | 116 | 106 | 124 | 71.00 | 100 | 202 | 243 | 225 | 169 | 123 | 142 | 78.00 | 61.00 |
Net PPE | - | - | - | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 2.00 | 1.00 | 1.00 | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 |
Liabilities | -47.3% | 24.00 | 45.00 | 53.00 | 54.00 | 51.00 | 53.00 | 40.00 | 42.00 | 39.00 | 61.00 | 49.00 | 25.00 | 21.00 | 18.00 | 20.00 | 16.00 | 18.00 |
Current Liabilities | -73.0% | 8.00 | 28.00 | 33.00 | 31.00 | 25.00 | 24.00 | 21.00 | 22.00 | 19.00 | 38.00 | 24.00 | 21.00 | 16.00 | 12.00 | 14.00 | 9.00 | 9.00 |
Shareholder's Equity | -17.4% | 120 | 146 | 195 | 229 | 194 | 225 | 253 | 158 | 192 | 225 | 267 | 302 | 330 | 353 | 374 | - | - |
Retained Earnings | -4.6% | -686 | -656 | -596 | -552 | -506 | -465 | -427 | -385 | -385 | -297 | -239 | -193 | -156 | -125 | -99.90 | -76.29 | -55.32 |
Additional Paid-In Capital | 0.6% | 807 | 802 | 792 | 782 | 701 | 691 | 681 | 544 | 533 | 522 | 507 | 496 | 486 | 478 | 474 | 5.00 | 4.00 |
Shares Outstanding | 0.6% | 115 | 114 | 114 | 114 | 93.00 | 93.00 | 71.00 | 64.00 | 64.00 | 64.00 | 63.00 | 62.00 | - | - | - | - | - |
Float | - | - | - | - | 265 | - | - | - | 144 | - | - | - | 599 | - | - | - | - | - |
Cashflow (Quarterly) | |||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 |
Cashflow From Operations | -44.4% | -44,380 | -30,735 | -34,476 | -27,122 | -32,118 | -31,571 | -35,127 | -28,878 | -46,476 | -28,068 | -36,437 | -22,888 | -18,926 | -21,093 | -18,057 | -11,118 | -10,543 | - | - | - |
Share Based Compensation | -49.6% | 5,034 | 9,994 | 10,468 | 10,288 | 10,029 | 9,042 | 10,855 | 10,951 | 10,467 | 15,860 | 10,286 | 9,726 | 8,103 | 4,431 | 3,860 | 492 | 646 | - | - | - |
Cashflow From Investing | 58.6% | 40,000 | 25,218 | -66,851 | 37,894 | 41,724 | 13,537 | -38,557 | -479 | -54,979 | -13,523 | 54,967 | 79,712 | 64,827 | 1,922 | -210,263 | 25,005 | 13,839 | - | - | - |
Cashflow From Financing | -100.0% | - | 11.00 | - | - | - | 292 | 126,425 | - | - | 65.00 | - | - | - | -354 | - | - | - | - | - | - |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED) - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Operating expenses: | ||
Research and development | $ 12,173 | $ 30,718 |
General and administrative | 10,662 | 12,513 |
Restructuring costs | 9,464 | |
Total operating expenses | 32,299 | 43,231 |
Loss from operations | (32,299) | (43,231) |
Total other income (loss), net: | ||
Interest income | 1,246 | 1,325 |
Other income (loss), net | 754 | 723 |
Net loss | $ (30,299) | $ (41,183) |
Net loss per share - basic | $ (0.26) | $ (0.44) |
Net loss per share - diluted | $ (0.26) | $ (0.44) |
Weighted-average common shares outstanding - basic | 114,690,726 | 93,303,672 |
Weighted-average common shares outstanding - diluted | 114,690,726 | 93,303,672 |
Comprehensive loss: | ||
Net Income (Loss) | $ (30,299) | $ (41,183) |
Other comprehensive income (loss), net of tax: | ||
Unrealized (loss) gain on available-for-sale securities | (76) | 167 |
Total other comprehensive income (loss) | (76) | 167 |
Comprehensive loss | $ (30,375) | $ (41,016) |
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 86,039 | $ 90,121 |
Short-term investments | 54,491 | 93,822 |
Interest receivable | 181 | 206 |
Prepaid expenses and other current assets | 771 | 3,486 |
Total current assets | 141,482 | 187,635 |
Restricted cash | 554 | 852 |
Other assets | 122 | |
Operating lease right-of-use assets | 2,107 | 2,187 |
Total assets | 144,143 | 190,796 |
Current liabilities: | ||
Accounts payable | 765 | 6,761 |
Accrued expenses | 4,596 | 10,086 |
Operating lease liability, current | 2,295 | 10,781 |
Total current liabilities | 7,656 | 28,367 |
Operating lease liability, long term | 16,047 | 16,648 |
Total liabilities | 23,703 | 45,015 |
Stockholders’ equity: | ||
Preferred stock, $0.0001 par value: 10,000,000 shares authorized at March 31, 2024 and December 31, 2023, respectively; 0 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively | ||
Common stock, $0.0001 par value: 300,000,000 shares authorized at March 31, 2024 and December 31, 2023, respectively; 114,881,765 and 114,153,538 shares issued at March 31, 2024 and December 31, 2023, respectively; and 114,881,765 and 114,148,991 shares outstanding at March 31, 2024 and December 31, 2023, respectively | 11 | 11 |
Additional paid-in capital | 807,059 | 802,025 |
Accumulated other comprehensive loss | (138) | (62) |
Accumulated deficit | (686,492) | (656,193) |
Total stockholders’ equity | 120,440 | 145,781 |
Total liabilities and stockholders’ equity | $ 144,143 | 190,796 |
Related Party | ||
Current liabilities: | ||
Amount due to related party | $ 739 |